28 studies found for:    Open Studies | "Hemorrhagic Fevers, Viral"
Show Display Options
Rank Status Study
1 Recruiting Phase 2a Immunogenicity Study of Hantaan/Puumala Virus DNA Vaccine for Prevention of Hemorrhagic Fever
Condition: Hemorrhagic Fever With Renal Syndrome
Interventions: Biological: HTNV/PUUV DNA vaccine;   Biological: Placebo
2 Recruiting Clinical Trial of the cAd3-EBO and cAd3-EBOZ Ebola Vaccines in Healthy Adults in Uganda
Condition: Hemorrhagic Fever, Ebola
Interventions: Biological: cAd3-EBOZ;   Biological: cAd3-EBO
3 Not yet recruiting STRIVE (Sierra Leone Trial to Introduce a Vaccine Against Ebola)
Condition: Hemorrhagic Fever, Ebola
Intervention: Biological: rVSVΔG-ZEBOV
4 Recruiting Emergency Evaluation of Convalescent Plasma for Ebola Viral Disease (EVD) in Guinea
Condition: Hemorrhagic Fever, Ebola
Intervention: Other: Convalescent Plasma
5 Recruiting Phase I Trial to Assess the Safety, Tolerability and Immunogenicity of a Ebola Virus Vaccine (rVSVΔG-ZEBOV-GP)
Condition: Hemorrhagic Fever, Ebola
Intervention: Biological: rVSVΔ-ZEBOV-GP
6 Recruiting Chinese and Western Medicine Treatment of Fever Associated With Bleeding Symptoms
Conditions: Viral Haemorrhagic Fever;   Dengue Fever
Interventions: Drug: Western Medicine;   Drug: TCM  and  Western Medicine
7 Recruiting Immunologic Mechanisms of Immune Interference and/or Cross-Neutralizing Immunity After CYD Tetravalent Dengue Vaccine
Conditions: Dengue;   Dengue Fever;   Dengue Hemorrhagic Fever
Interventions: Biological: CYD Dengue Vaccine;   Biological: CYD Dengue and Japanese Encephalitis Vaccines;   Biological: Japanese Encephalitis and CYD Dengue Vaccines
8 Not yet recruiting Ebola CVD-Mali #2000 (Bivalent) VRC-EBOAdc069-00-vp (cAd3-EBO)
Conditions: Ebola Virus Disease;   Hemorrhagic Fever
Intervention: Biological: VRC-EBOADC069-00-vp
9 Not yet recruiting Multiple Treatments for Ebola Virus Disease (EVD)
Condition: Ebola Virus Disease
Interventions: Drug: Azithromycin;   Drug: Sunitinib and Erlotinib;   Drug: Atorvastatin and Irbesartan;   Other: IV fluids and laboratory testing
10 Recruiting A Prospective, Open Label, Phase 1 Safety Study of Passive Immune Therapy During Acute Ebola Virus Infection Using Transfusion of INTERCEPT Plasma Prepared From Volunteer Donors Who Have Recovered From Ebola Virus Infection
Condition: Acute Ebola Virus Infection
Intervention: Biological: INTERCEPT Plasma
11 Recruiting A Phase 1 Study to Evaluate the Safety, Tolerability and Pharmacokinetics of BCX4430
Conditions: Filovirus Infections;   Ebola Virus Infection
Interventions: Drug: BCX4430;   Drug: Placebo
12 Recruiting Efficacy of Favipiravir Against Ebola (JIKI)
Condition: Ebola Virus Disease
Intervention: Drug: Favipiravir
13 Recruiting Clinical Trial to Evaluate the Efficacy and Safety of Convalescent Plasma for Ebola Treatment
Condition: Ebola Virus Disease
Intervention: Procedure: Convalescent Plasma Treatment
14 Unknown  West Indies-French Guiana Dengue Study
Conditions: Fever;   Dengue
Interventions: Other: biological sample collection;   Other: quality of life questionnaire EuroQol®
15 Unknown  Prospective Study of Infant Dengue
Condition: Dengue
Intervention:
16 Recruiting Adult Dengue Platelet Study
Condition: Dengue Fever
Interventions: Procedure: Platelet transfusion;   Other: Supportive care
17 Recruiting Immune Responses to Yellow Fever Vaccine
Condition: Prior Receipt of Yellow Fever Vaccine
Intervention:
18 Recruiting Turnover of Antigen Specific Lymphocytes After Immunization With the Yellow Fever Vaccine
Condition: Yellow Fever
Interventions: Biological: Yellow fever vaccine;   Biological: Yellow fever vaccine and D20 water
19 Recruiting Human Immune Responses to The Yellow Fever Virus Vaccine
Condition: Yellow Fever
Intervention: Biological: Yellow fever vaccine
20 Recruiting Investigation of the Immuno-regulation and Viral Hepatitis Among Patients With or After Dengue Fever Infection
Condition: Dengue Fever
Intervention: Genetic: CLEC5A

   Previous Page Studies Shown (1-20) Next Page (21-28) Show next page of results    Last Page
Indicates status has not been verified in more than two years